ASSOCIATION BETWEEN SKIN AUTOFLUORESCENCE AND RENAL FUNCTION MARKERS IN NON-DIABETIC VIETNAMESE ADULTS

Lê Minh Khang Đặng, Mỹ Ngân Tăng, Quốc Tuấn Lê

Main Article Content

Abstract

Background: Advanced glycation end-products (AGEs) are compounds that bind to proteins and exhibit fluorescent properties, which can be non-invasively measured as skin autofluorescence (SAF). SAF has been shown to be a biomarker of AGE accumulation in the skin and a better predictor of chronic complications in diabetic patients. Since studies on SAF in non-diabetic adults are still limited, this study was conducted to investigate the relationship between SAF levels and clinical and paraclinical parameters in non-diabetic Vietnamese adults. Methods: A cross-sectional study was conducted on 53 non-diabetic Vietnamese adults visiting the University Medical Center Ho Chi Minh City. SAF values, along with clinical and paraclinical data, were collected. Spearman and Pearson correlation analyses and Student’s t-test were used to assess the associations. Results: SAF levels were significantly higher in participants with hypertension (p<0.05) and those with a history of coronary artery disease (p<0.05) compared to those without these conditions. SAF showed significant positive correlations with age (r = 0.495, p<0.001), HbA1c (r = 0.31, p<0.05), fasting blood glucose (r = 0.36, p<0.01), and serum cystatin C levels (r = 0.44, p<0.01). Significant negative correlations were found between SAF and serum albumin levels (r = -0.39, p<0.01) as well as estimated glomerular filtration rate (eGFR) (r = -0.41, p<0.01). Conclusions: The significant associations between SAF—a marker of AGE accumulation in the skin—and age, HbA1c, fasting glucose, cystatin C, albumin, and eGFR suggest that SAF may serve as an early indicator of metabolic, cardiovascular, and renal risks even in non-diabetic individuals.

Article Details

References

Mulder DJ, Water TVD, Lutgers HL, et al. Skin Autofluorescence, a Novel Marker for Glycemic and Oxidative Stress-Derived Advanced Glycation Endproducts: An Overview of Current Clinical Studies, Evidence, and Limitations. Diabetes Technology & Therapeutics. 2006;8(5): 523-535. doi:10.1089/dia.2006.8.523
2. Bos DC, de Ranitz-Greven WL, de Valk HW. Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review. Diabetes Technology & Therapeutics. 2011;13(7):773-779. doi:10.1089/dia.2011.0034
3. van Waateringe RP, Fokkens BT, Slagter SN, et al. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population. Diabetologia. Feb 2019; 62(2):269-280. doi:10.1007/s00125-018-4769-x
4. van Waateringe RP, Slagter SN, van Beek AP, et al. Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. Diabetology & Metabolic Syndrome. 2017/05/30 2017;9(1):42. doi:10.1186/s13098-017-0241-1
5. van Waateringe RP, Slagter SN, van der Klauw MM, et al. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study. European Journal of Clinical Investigation. 2016;46(5):481-490. doi:https://doi.org/10.1111/eci.12627
6. den Dekker MAM, Zwiers M, van den Heuvel ER, et al. Skin Autofluorescence, a Non-Invasive Marker for AGE Accumulation, Is Associated with the Degree of Atherosclerosis. PLOS ONE. 2013;8(12): e83084. doi:10.1371/journal.pone. 0083084
7. Fewkes JJ, Dordevic AL, Murray M, Williamson G, Kellow NJ. Association between endothelial function and skin advanced glycation end-products (AGEs) accumulation in a sample of predominantly young and healthy adults. Cardiovascular Diabetology. 2024/09/09 2024; 23(1):332. doi:10.1186/s12933-024-02428-3
8. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. Jan 10 2004;363(9403): 157-63. doi:10.1016/s0140-6736(03)15268-3
9. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition. Lancet. Sep 24-30 2005;366(9491):1059-62. doi:10.1016/ s0140-6736(05)67402-8
10. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018/06/01 2018; 71(6): e13-e115. doi:10.1161/HYP. 0000000000000065